Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase

被引:48
|
作者
Wiegmann, K
Schwandner, R
Krut, O
Yeh, WC
Mak, TW
Krönke, M
机构
[1] Univ Kiel, Inst Immunol, D-24105 Kiel, Germany
[2] Univ Toronto, Amgen Inst, Toronto, ON M5G 2M9, Canada
[3] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
关键词
D O I
10.1074/jbc.274.9.5267
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The generation of mice strains deficient for select members of the signaling complex of the 55-kDa tumor necrosis factor receptor (TNF-R55) has allowed the assignment of specific cellular responses to distinct TNF-R55-associated proteins. In particular, the TNF-R55-associated protein FADD seems to be responsible for recruitment and subsequent activation of caspase 8. In this report we demonstrate the requirement of FADD for TNF-induced activation of endosomal acid sphingomyelinase (A-SMase), In primary embryonic fibroblasts from FADD-deficient mice the activation of A-SMase by TNF-R55 ligation was almost completely impaired. This effect is specific in that other TNF responses like activation of NF-kappa B or neutral (N-)SMase remained unaffected. In addition, interleukin-l-induced activation of A-SMase in FADD-deficient cells was unaltered. In FADD(-/-) embryonic fibroblasts reconstituted by transfection with a FADD cDNA expression construct, the TNF responsiveness of A-SMase was restored. The results of this study suggest that FADD, in addition to its role in triggering a proapoptotic caspase cascade, is required for TNF-induced activation of A-SMase.
引用
收藏
页码:5267 / 5270
页数:4
相关论文
共 50 条
  • [1] Requirement of FADD, NEMO, and BAX/BAK for Aberrant Mitochondrial Function in Tumor Necrosis Factor Alpha-Induced Necrosis
    Irrinki, Krishna M.
    Mallilankaraman, Karthik
    Thapa, Roshan J.
    Chandramoorthy, Harish C.
    Smith, Frank J.
    Jog, Neelakshi R.
    Gandhirajan, Rajesh Kumar
    Kelsen, Steven G.
    Houser, Steven R.
    May, Michael J.
    Balachandran, Siddharth
    Madesh, Muniswamy
    MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (18) : 3745 - 3758
  • [2] Involvement of fas receptor and not tumor necrosis factor-α receptor in ultraviolet-induced activation of acid sphingomyelinase
    Chatterjee, M
    Wu, SY
    MOLECULAR CARCINOGENESIS, 2001, 30 (01) : 47 - 55
  • [3] INHIBITORS OF POLYAMINE BIOSYNTHESIS BLOCK TUMOR NECROSIS FACTOR-INDUCED ACTIVATION OF MACROPHAGES
    KACZMAREK, L
    KAMINSKA, B
    MESSINA, L
    SPAMPINATO, G
    ARCIDIACONO, A
    MALAGUARNERA, L
    MESSINA, A
    CANCER RESEARCH, 1992, 52 (07) : 1891 - 1894
  • [4] Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase
    Luberto, C
    Hassler, DF
    Signorelli, P
    Okamoto, Y
    Sawai, H
    Boros, E
    Hazen-Martin, DJ
    Obeid, LM
    Hannun, YA
    Smith, GK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) : 41128 - 41139
  • [5] TUMOR NECROSIS FACTOR-INDUCED TUMOR KILLING INVOLVES COAGULATION
    NAWROTH, PP
    HANDLEY, DA
    STERN, DM
    CIRCULATION, 1986, 74 (04) : 233 - 233
  • [6] Cathepsin B mediates tumor necrosis factor-induced arachidonic acid release in tumor cells
    Foghsgaard, L
    Lademann, U
    Wissing, D
    Poulsen, B
    Jäättelä, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 39499 - 39506
  • [7] Ras signaling in tumor necrosis factor-induced apoptosis
    Trent, JC
    McConkey, DJ
    Loughlin, SM
    Harbison, MT
    Fernandez, A
    Ananthaswamy, HN
    EMBO JOURNAL, 1996, 15 (17): : 4497 - 4505
  • [8] PENTOXIFYLLINE AND TUMOR NECROSIS FACTOR-INDUCED LUNG INJURY
    ZABEL, P
    SCHADE, FU
    EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (08) : 1389 - 1391
  • [9] TUMOR NECROSIS FACTOR-INDUCED NECROSIS - A MONOCYTE MEDIATED HYPERCOAGULABLE EFFECT
    SPILLERT, CR
    SUN, S
    PONNUDURAI, R
    MILLER, MA
    LAZARO, EJ
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1995, 87 (07) : 508 - 509
  • [10] TUMOR NECROSIS FACTOR-INDUCED BOWEL NECROSIS - THE ROLE OF PLATELET-ACTIVATING FACTOR
    HSUEH, W
    SUN, XM
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 : 363 - 366